Joseph D. Robinson has devoted most of his career to advancing the research, treatment, and prevention of infectious diseases, with a focus on HIV/AIDS, HCV. He began his professional path as the practice administrator for Marcus A. Conant, M.D., leading administrative operations for the Conant Medical Group—the largest private HIV practice in San Francisco.
Joe later transitioned into the life sciences industry, joining VaxGen under the leadership of Donald P. Francis, M.D., where he contributed to the first Phase III preventive vaccine trials targeting sexually transmitted and community‑acquired HIV. He subsequently joined Presidio Pharmaceuticals, supporting the development of an effective antiviral therapy for HCV. Today, Joe leads operations at Nurix Therapeutics, which is engaged in early drug discovery and development efforts to identify novel drugs aimed at treating cancer and immunological and inflammatory diseases.
Beyond his scientific and operational work, Joe has been deeply involved in community service and nonprofit leadership. He was the founding Secretary of both the Conant Foundation and the Rainbow Honor Walk, the latter of which he has served since its inception. Previously, he served as Team Manager for the San Francisco RockDogs basketball team. Over nearly four decades, Joe has extensively supported HIV transmission prevention efforts.
He resides in San Francisco with his spouse.